| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |